ICICI Bank, Divi’s Among 14 NSE 500 Stocks Hit Muhurat Session Highs

Diwali Session Sets Fresh Highs Across a Diverse Group of Stocks

A cluster of lifetime peaks brought bank, pharma, financial and industrial names into focus, with recent earnings providing a clear catalyst for some of the strongest moves.

The special session on Sunday, November 8, brought a broad set of NSE 500 stocks to record levels. The development is notable for its reach: the names included a major private-sector bank, pharmaceutical companies, a port operator, a market-services firm, an electric two-wheeler maker and consumer businesses. But a lifetime high in one trading session is a signal to examine, not by itself evidence that a stock’s next move is assured.

Record highs spanned multiple corners of the market

Alongside ICICI Bank, Divi’s Laboratories and MCX India, the stocks named among those reaching lifetime highs included Motilal Oswal Financial Services, Ather Energy, Adani Ports, Navin Fluorine, Indian Hotels, Emcure Pharmaceuticals, TVS Motor Company, Aurobindo Pharma, Marico and Shyam Metalics. The range makes the session more than a story about one industry or one earnings announcement.

The source gives specific intraday moves for only some of these shares. It reported that Ather Energy, Adani Ports and MCX India were each up about 1% in the session, while other stocks reached highs without a move being specified. Investors should therefore distinguish the fact of a record price from the size and durability of any accompanying rally.

Earnings gave Divi’s and Emcure a measurable catalyst

Divi’s Laboratories rose 6% to ₹10,950 after reporting a 63.6% year-on-year increase in Q2FY27 net profit to ₹1,127 crore, from ₹689 crore a year earlier. Revenue from operations grew 35.4% to ₹3,676 crore, compared with ₹2,715 crore. The combination of stronger profit and revenue offers investors a specific operating development to assess alongside the stock’s new high.

Emcure Pharmaceuticals also paired a record price with reported growth in its latest quarter. Its consolidated net profit rose 33.7% year on year to ₹325.5 crore, while revenue from operations increased 24.2% to ₹2,820.4 crore. The stock reached ₹2,430. These figures provide context for the rally, but one quarter alone does not establish whether the pace of growth will continue.

Other advances had different reported drivers

Motilal Oswal Financial Services gained more than 4% to ₹1,147 and was higher for a sixth consecutive trading session. The report linked investor hopes of a possible review of long-term capital gains tax to improving market sentiment and participation. That remains an expectation, not a confirmed policy change, so the share’s advance should not be treated as proof that a tax review will happen.

Shyam Metalics climbed nearly 4% to ₹1,353.30 and was still up more than 3% at 3 p.m. The account did not identify a specific catalyst for every other stock at a fresh high. That distinction matters: record levels can reflect company-specific results, investor expectations or broader buying, and the available information does not establish one common cause.

What investors can take from a special-session record

Muhurat trading is a single, special session; the reported highs are a snapshot rather than a verdict on future performance. Investors weighing these stocks can separate earnings-supported moves from advances tied to expectations, then assess whether the business evidence supports the valuation implied by a record price. The article provides no valuation comparisons or longer-term performance data, so those questions cannot be settled by the session alone.

Key Highlights

• Fourteen NSE 500 stocks reached lifetime highs during the Diwali Muhurat session.
• Divi’s Laboratories rose 6% to ₹10,950 after reporting higher Q2FY27 profit and revenue.
• Emcure Pharmaceuticals reached ₹2,430, with year-on-year growth in both reported profit and revenue.
• Motilal Oswal Financial Services advanced more than 4%; hopes of an LTCG tax review were cited as a sentiment factor, not a confirmed change.
• The record list covered several industries, while specific catalysts were not provided for every stock.

Investor Note: Treat a Muhurat-session lifetime high as a prompt for further research, not a standalone buy signal. Compare the company’s reported business performance and outlook with the price investors are paying, and distinguish confirmed developments from market expectations.